Mono-2-ethylhexyl Phthalate Test · Urine

You probably encounter a chemical called di(2-ethylhexyl) phthalate, or DEHP, dozens of times a day without thinking about it. It softens the plastic in food packaging, vinyl flooring, shower curtains, IV bags, and medical tubing, and it leaches into the food and drinks that touch it. Your body breaks DEHP down into a smaller molecule called MEHP (mono-2-ethylhexyl phthalate), which then exits in your urine.

Measuring urinary MEHP gives you a window into how much DEHP you have actually absorbed in the past day or so. Higher levels have been linked in human studies to thyroid disruption, metabolic problems, fertility issues, and higher death rates in vulnerable groups. Because almost no standard panel includes phthalate breakdown products, this is one of the few ways to see whether plastic chemicals are quietly accumulating in your routine.

What This Test Actually Measures

MEHP is the main single-ester product your body makes when it splits DEHP apart in your gut and bloodstream. It is not a hormone, enzyme, or protein your body produces. It only exists in you because DEHP got in. Your body then converts much of MEHP into other oxidized forms (MEHHP, MEOHP, MECPP) before excreting them. Urinary MEHP itself usually accounts for a smaller share of total DEHP excretion than these oxidized forms.

DEHP and its breakdown products have a short biological half-life, under 24 hours. That means a urine MEHP result reflects very recent exposure (the last day or two), not long-term body burden. That is why one reading is a snapshot, not a verdict. The clinical use of MEHP is exploratory, not diagnostic. It does not name a disease. It tells you how much of one widespread plastic chemical your body is processing right now.

Why Your Exposure Matters

DEHP is one of the most studied endocrine-disrupting chemicals in the world, meaning it can interfere with hormone signaling. The breakdown product this test measures has been associated in human studies with disturbances in thyroid function, sex hormones, lipid handling, glucose control, immune signaling, and fetal development. The links are statistical, not deterministic, but they are consistent enough across populations that regulators in Europe and the US have set tolerable intake limits for DEHP.

Diet is a dominant source. A study of more than 17,000 adults found that people eating takeout food more than seven times a week had higher DEHP exposure and a higher risk of inflammatory bowel disease. Meat, poultry, protein-rich foods, and dietary staples have been identified as major contributors in dietary modeling work. Medical exposure through IV bags and tubing also drives high readings, which is why hemodialysis patients show some of the highest serum MEHP levels documented.

Heart Disease and Mortality

Higher urinary DEHP breakdown products have been tied to higher risk of dying from heart disease and from any cause in U.S. adults aged 40 and older (a study of 6,625 people from NHANES). In adults with diabetes, a separate analysis of 8,931 people found the same pattern: higher phthalate levels predicted higher all-cause and cardiovascular mortality. In hemodialysis patients, those with serum MEHP at or above 41.8 ng/mL had markedly higher risk of death and major cardiovascular and infectious complications compared to those below 7.89 ng/mL.

Mechanistically, higher MEHP exposure has been linked in young adults to thicker carotid artery walls (an early sign of atherosclerosis, the buildup of plaque in arteries) and to changes in DNA chemistry that can switch genes on or off. In a study of 793 young Taiwanese adults, urinary DEHP breakdown products correlated with carotid intima-media thickness, a measurement used to detect silent vascular damage years before symptoms appear.

Metabolic Disease and Obesity

A meta-analysis of phthalate exposure and diabetes concluded that DEHP breakdown products, including MEHP, are associated with higher risk of type 2 diabetes. In a case-control study of 412 adults, cell damage caused by unstable molecules acting through a fat-and-sugar regulator called the PPAR receptor appeared to mediate part of the link. In 786 young Taiwanese adults, urinary MEHP was associated with insulin resistance and lower testosterone in young men but not in adolescents.

MEHP exposure has also been associated with non-alcoholic fatty liver disease (NAFLD) in U.S. adults. Multiple NHANES analyses have found that higher urinary DEHP breakdown products correlate with imaging-confirmed liver fat. Studies in the Aragon Workers' Health Study (1,124 participants) link higher urinary DEHP and its breakdown products to general obesity, and pediatric work has tied higher levels to changes in adipokines, the hormones fat tissue uses to communicate with the rest of the body.

Thyroid Function

A meta-analysis of human studies concluded that DEHP exposure is significantly associated with disruption of the hypothalamus-pituitary-thyroid axis, the brain-and-gland system that regulates your metabolism. In 408 adult men, higher urinary MEHP was inversely associated with free T4 and T3, the active thyroid hormones. In 144 children, urinary phthalate breakdown products dominated by MEHP were dose-responsively associated with higher TSH (the brain signal telling the thyroid to work harder), and the inflammatory protein IL-16 mediated part of that effect.

Pregnancy and Fetal Development

MEHP crosses the placenta. In a study of 84 mothers and newborns, MEHP was detected in 88% of cord blood samples and was associated with shorter pregnancy duration. A systematic review of prenatal phthalate exposure found links to pregnancy complications and fetal neurodevelopmental disorders, with the first trimester appearing to be the most sensitive window.

In 514 mother-infant pairs from the Hokkaido Study, higher maternal MEHP was associated with reduced reproductive hormone levels in cord blood, suggesting potential interference with male reproductive development. In 781 children, prenatal DEHP exposure was tied to increased risks of allergies and infectious diseases up to age seven.

Reference Ranges

There are no standardized clinical reference ranges for urinary MEHP. The values below come from published biomonitoring studies in defined populations. They are illustrative orientation, not universal targets. Your lab may report results in different units, and creatinine correction (per gram of creatinine) is the convention for accounting for how dilute or concentrated your urine sample is.

Compare your results within the same lab over time for the most meaningful trend. Lower is generally considered better, since MEHP has no known beneficial role in the body.

Tracking Your Trend

A single MEHP measurement is unreliable on its own. In a study of eight adults sampled over one week, the within-person variability for DEHP breakdown products averaged 161%, with large swings between morning and evening readings. In a fertility cohort, the reproducibility of total DEHP breakdown products in pregnant women was very low (a statistical reproducibility score of 0.08, where 1.0 would be perfect agreement). The takeaway is that one urine sample captures the last day or two of exposure, not your typical level.

To get a meaningful read, plan on serial testing. A reasonable cadence is a baseline test, a follow-up in 3 to 6 months after making changes (switching food storage, replacing vinyl items, changing your takeout habits), and at least annual checks thereafter. If you are pregnant, planning to be, or working on lowering your overall toxic burden, more frequent testing makes sense. Look at the direction of your trend rather than getting fixated on any single number.

When Results Can Be Misleading

• Recent food intake: A meal eaten in plastic packaging or takeout containers within the last 24 hours can sharply raise your urinary MEHP. The level reflects recent exposure, not long-term body burden.
• Time of day: DEHP breakdown products swing significantly throughout the day. First-morning urine is generally more reproducible than spot samples taken later.
• Hydration: Dilute urine can lower the raw concentration. Creatinine adjustment accounts for this, but extreme over- or under-hydration can still skew the result.
• Recent medical exposure: IV fluids, blood transfusions, or contact with PVC medical tubing in the days before testing can produce sharply elevated levels that do not reflect your usual exposure.

What to Do if Your Levels Are High

An elevated urinary MEHP is not a diagnosis. It is a signal that your recent DEHP exposure is on the higher end of what is typical for the population. The first step is to retest after two to three weeks of changing the most likely sources: cooking and storing food in glass or stainless steel instead of plastic, cutting back on takeout and processed foods, replacing vinyl shower curtains and flooring, and choosing personal care products labeled phthalate-free.

If your level remains elevated after lifestyle changes, consider testing the rest of the phthalate panel (MEOHP, MEHHP, MECPP, MEP, MBP) to see whether you have broad phthalate exposure or just one source. If you have a specific concern (a thyroid issue, fertility difficulty, or persistent metabolic problem), bring the result to a physician familiar with environmental medicine. There is no specific medication that lowers MEHP. Reducing exposure is the only proven approach.